Helpful Links:

Mouse over texts (on all home page segments) to find clickable links which will appear in red!

> Directions & Location map

> Meetings Information
> Speakers Information
> Donate
> Contact
> Other Local Southern California Support Groups
> National PCa Links of Interest

Links to interesting articles which appeared in our 2016 Monthly Bulletins have been moved to this link,  (An edited copy of the November 2016 bulletin with intact links)

Interesting Prostate Cancer treatment related articles published or sourced by Glenn Tisman, M.D.  can be found here!

Dr. Tisman's recently launched Facebook page is linked here and his web site here and his most recent cancer newsletter here:

Answers to your Medicare Part A, B and D questions at this link:

Stay Informed

Sign up for our Monthly Programs Bulletins by email  > Click here to sign up

Christopher Saigal, M.D, MPH.

Dr. Saigal spoke at the Prostate Forum on May 23, 2013, at 7 PM. Our video #475 refers.

Subject: MRI Guided Biopsy of the Prostate.

Hear Dr. Saigal speak about the latest imaging technology and how to make active surveillance a safe alternative to invasive treatments for prostate cancer.

For more than a quarter-century, transrectal ultrasound has been the standard imaging technique for systematic prostate biopsies. However, modern MRI provides superior resolution that could substantially improve prostate cancer detection.

The technique, which fuses MRI images with ultrasound, could revolutionize prostate cancer detection and supplant ultrasound-guided biopsies, which have been the standard of care for 25 years.

Targeted prostate biopsy with magnetic resonance imaging (MRI) tripled the cancer yield compared with conventional systematic biopsies. MRI-targeted lesions contained biopsy-proven prostate cancer 21% of the time, whereas systematic biopsy detected cancer just 7% of the time according to reports (source: Journal of Urology)

The technique has potentially widespread applicability to prostate cancer detection and for monitoring men who opt for active surveillance of clinically low-risk prostate cancer.

Dr. Saigal is an Associate professor and vice chair of the Department of Urology at UCLA. His surgical practice is at the Ronald Reagan Medical Center in Westwood. He serves as the Department of Urology Director of Health Services Research, as well as Director of Innovation.